Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse

Keyphrases

• Mitral Valve Prolapse 100%
• Cardiac Magnetic Resonance 40%
• Sudden Cardiac Death 40%
• Echocardiography 30%
• Complex Ventricular Arrhythmias 30%
• Inflammation 20%
• High Risk 20%
• Fibrosis 20%
• Risk Stratification 20%
• Ventricular Arrhythmia 20%
• Arrhythmia 20%
• Morphological Changes 20%
• Arrhythmias Cardiac 20%
• Mechanical Stretch 20%
• Valve Disease 20%
• Mitral 10%
• Mitral Valve 10%
• Clinical Significance 10%
• Cardiac Events 10%
• Cardiac Imaging 10%
• Interstitial Fibrosis 10%
• Multiple Conditions 10%
• Potential Risk 10%
• Speckle Tracking Echocardiography 10%
• Contrast Enhancement 10%
• Regurgitation 10%
• Functional Alterations 10%
• Functional Abnormalities 10%
• Structural Alterations 10%
• Arrhythmogenesis 10%
• Western World 10%
• Redundancy 10%
• Myocardial Fibrosis 10%
• Anatomical Changes 10%
• Myocardial Structure 10%
• Purkinje Fibers 10%
• Replacement Fibrosis 10%
• Prognosticator 10%
• Arrhythmic Risk Stratification 10%
• Annular Dilatation 10%
• Severity Assessment 10%
• Myocardial Hypertrophy 10%
• Annual Risk 10%
• Comprehensive Risk 10%
• Mechanical Alteration 10%
• Hybrid PET-MR 10%
• Morphofunctional 10%
• Structure Remodelling 10%
• Arrhythmia Risk Stratification 10%
• Mechanical Dispersion 10%
• Mitral Annular Disjunction 10%

Medicine and Dentistry

• Mitral Valve Prolapse 100%
• Heart Ventricle Arrhythmia 50%
• Risk Stratification 40%
• Cardiac Magnetic Resonance Imaging 40%
• Sudden Cardiac Death 40%
• Echocardiography 30%
• Cardiac Dysrhythmia 30%
• Morphology 30%
• Fibrosis 20%
• Valvular Heart Disease 20%
• Mitral Valve 10%
• Ventricular Hypertrophy 10%
• Cardiac Imaging 10%
• Arrhythmogenesis 10%
• Idiopathic Pulmonary Fibrosis 10%
• Mitral Annulus 10%
• Cardiac Fibrosis 10%
• Speckle Tracking Echocardiography 10%
• Polyethylene Terephthalate 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Mitral Valve Prolapse 100%
• Heart Ventricle Arrhythmia 50%
• Sudden Cardiac Death 40%
• Heart Arrhythmia 30%
• Inflammation 20%
• Fibrosis 20%
• Valvular Heart Disease 20%
• Syndrome 10%
• Arrhythmogenesis 10%
• Heart Ventricle Hypertrophy 10%
• Heart Muscle Fibrosis 10%
• Fibrosing Alveolitis 10%
• Polyethylene Terephthalate 10%